innovating in
Health
Improving human health and well-being
SRI has been a leader for decades in the development of tools, technologies, and therapeutics that have saved and improved countless lives around the world.
Our Biosciences division works with government and commercial clients to seamlessly integrate basic and translational research, drug discovery, and nonclinical and clinical development. But addressing the toughest healthcare problems means working collaboratively. With our expertise in AI, robotics, education and learning, and other fields and disciplines, we do pioneering work in areas that include AI-powered platforms for drug discovery, tele-robotic surgery, robotics and tele-manipulation for health care applications, diagnostics and sensing, adolescent mental health, and more. Contact us to learn more.
Innovating in
Real-world impact
-
SRI selected as DARPA’s Regional Commercial Accelerator
DARPA looks to harness SRI’s expertise to speed up tech transition — out of the lab into the real world — and scale DARPA-funded technologies for U.S. national and economic security outcomes.
-
The naked mole rat may hold the key to new treatments for neurodegenerative diseases
SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.
-
Engineered helper T cell could become a cancer killer
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.